يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"MESH: Gene Expression Regulation, Leukemic"', وقت الاستعلام: 1.24s تنقيح النتائج
  1. 1

    المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, The work was supported in part by grants from the Région Midi‐Pyrénées, the 'Fondation pour la Recherche Médicale' (programme Grands Equipements), European Fonds (FEDER), Toulouse metropole, 'Fond Social Européen' (FSE) and the 'Ligue contre le cancer' Grants., We thank Dr. Darragh O'Brien from Institut Pasteur for the careful reading of this manuscript., We thank members of the group for insightful comments related to this work. We would like to thank David Bouyssié for MFPAQ software and technical support. We would like also to thank our collaborators Stephane Manenti, for discussion. We Thanks Pr. Dr. Ruedi Aebersold from IMSB (ETH Zurich) for allowing the SRM measurement on the TSQ Vantage., Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Proteomics
    Proteomics, Wiley-VCH Verlag, 2017, Applications and Developments in Targeted Proteomics, 17 (7), pp.1600089. ⟨10.1002/pmic.201600089⟩

    مصطلحات موضوعية: 0301 basic medicine, MESH: Gene Ontology, Technology, Leupeptins, Cellular differentiation, Cell Cycle Proteins, Apoptosis, MESH: Cell Cycle / drug effects, Biochemistry, SILAC, MESH: Interleukins / metabolism, Bortezomib, MESH: Leukocytes / drug effects, Leukocytes, MESH: Interleukins / genetics, MESH: Apoptosis Regulatory Proteins / metabolism, Protein Isoforms, Proteasome inhibitor, Phosphorylation, MESH: Proteasome Endopeptidase Complex / drug effects, Targeted proteomics, Heat-Shock Proteins, MESH: Proteasome Endopeptidase Complex / metabolism, MESH: Computational Biology, Chemistry, Gene Expression Regulation, Leukemic, Cell Cycle, MESH: Apoptosis / drug effects, Cell Differentiation, Cell cycle, MESH: Phosphorylation / drug effects, MESH: Cell Cycle Proteins / metabolism, 3. Good health, Cell biology, MESH: Cell Cycle Proteins / genetics, MESH: Heat-Shock Proteins / genetics, Proteasome Inhibitors, medicine.drug, Research Article, Signal Transduction, MESH: Cell Differentiation, Proteasome Endopeptidase Complex, MESH: Cell Line, Tumor, Quantitative proteomics, MESH: Tumor Suppressor Protein p53 / metabolism, MESH: Protein Isoforms / genetics, MESH: Acetylcysteine / pharmacology, MESH: Molecular Sequence Annotation, MESH: Apoptosis Regulatory Proteins / genetics, MESH: Transcription Factors / genetics, MESH: Protein Isoforms / metabolism, 03 medical and health sciences, MESH: Gene Expression Profiling, MESH: Leukocytes / pathology, Heat shock protein, Cell Line, Tumor, medicine, MESH: Acetylcysteine / analogs & derivatives, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Cell Cycle Protein, Molecular Biology, MESH: Proteasome Inhibitors / pharmacology, MESH: Transcription Factors / metabolism, MESH: Humans, MESH: Leupeptins / pharmacology, Gene Expression Profiling, Interleukins, Computational Biology, Molecular Sequence Annotation, MESH: Bortezomib / pharmacology, MESH: Tumor Suppressor Protein p53 / genetics, MESH: Heat-Shock Proteins / metabolism, MESH: Leukocytes / metabolism, Acetylcysteine, 030104 developmental biology, Gene Ontology, Proteasome, MESH: Gene Expression Regulation, Leukemic / drug effects, Tumor Suppressor Protein p53, Apoptosis Regulatory Proteins, Human acute myeloid leukemia (AML) cells, Transcription Factors

  2. 2

    المساهمون: Institut de génétique humaine (IGH), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Cytoskeleton and Cell Plasticity Lab, Université du Luxembourg (Uni.lu), Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), University of British Columbia (UBC), Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche Public Santé, CRP-Santé Luxembourg, Sigma-Proligo, Granulopoiese et Processus Leucemiques (UMR_S_718), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Institut de génétique humaine ( IGH ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Université du Luxembourg ( Uni.lu ), Institut de Génétique Moléculaire de Montpellier ( IGMM ), University of British Columbia ( UBC ), Institut de pharmacologie moléculaire et cellulaire ( IPMC ), Université Nice Sophia Antipolis ( UNS ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ) -Centre National de la Recherche Scientifique ( CNRS ), Granulopoiese et Processus Leucemiques, Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM )

    المصدر: Blood
    Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. ⟨10.1182/blood-2008-05-158139⟩
    Blood, American Society of Hematology, 2009, 113 (2), pp.412-21. 〈10.1182/blood-2008-05-158139〉

    مصطلحات موضوعية: Oncogene Proteins, Fusion, Transcription, Genetic, Retinoic acid, MESH : Leukemia, Promyelocytic, Acute, MESH : Oncogene Proteins, Fusion, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Leukemia, Promyelocytic, Acute, MESH : Tumor Markers, Biological, MESH : Homeodomain Proteins, RNA, Neoplasm, MESH : Tretinoin, Regulation of gene expression, 0303 health sciences, Gene Expression Regulation, Leukemic, Myeloid leukemia, Hematology, MESH : Arsenic, 3. Good health, MESH : Antineoplastic Agents, Leukemia, 030220 oncology & carcinogenesis, MESH: Cell Adhesion Molecules, MESH: Gene Expression Regulation, Leukemic, medicine.drug, Acute promyelocytic leukemia, MESH: Cell Line, Tumor, Immunology, Antineoplastic Agents, Tretinoin, Biology, MESH : Cell Adhesion Molecules, Arsenic, 03 medical and health sciences, Cell Line, Tumor, MESH: Arsenic, MESH: Homeodomain Proteins, microRNA, Biomarkers, Tumor, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, [ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology, 030304 developmental biology, Homeodomain Proteins, MESH: Tretinoin, MESH: Humans, MESH : Cell Line, Tumor, MESH: Transcription, Genetic, MESH : Humans, MESH : Transcription, Genetic, Cell Biology, MESH: RNA, Neoplasm, medicine.disease, MESH : MicroRNAs, MicroRNAs, MESH : RNA, Neoplasm, MESH : Gene Expression Regulation, Leukemic, chemistry, Retinoic acid receptor alpha, MESH: Tumor Markers, Biological, Cancer research, MESH: Antineoplastic Agents, Cell Adhesion Molecules, MESH: MicroRNAs, MESH: Leukemia, Promyelocytic, Acute, MESH: Oncogene Proteins, Fusion

  3. 3

    المساهمون: UCL - SSS/DDUV/GECE - Génétique cellulaire, UCL - SSS/DDUV/MEXP - Médecine expérimentale, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de biologie hématologique, UCL - (SLuc) Service d'hématologie, Centre National de la Recherche Scientifique (CNRS)

    المصدر: Cellular and Molecular Life Sciences, Vol. 73, no. 24, p. 4739-4748 (2016)
    Cellular and Molecular Life Sciences
    Cellular and Molecular Life Sciences, Springer Verlag, 2016, 73 (24), pp.4739-4748. ⟨10.1007/s00018-016-2310-2⟩

    مصطلحات موضوعية: 0301 basic medicine, Genome instability, MESH: Oncogenes, DNA mismatch repair, Tyrosine kinase inhibitor, medicine.disease_cause, Tyrosine-kinase inhibitor, MESH: Down-Regulation, Mice, 0302 clinical medicine, MESH: DNA Methylation, RNA interference, MESH: RNA, Small Interfering, MESH: Janus Kinases, MESH: Protein Kinase Inhibitors, MESH: Animals, RNA, Small Interfering, Promoter Regions, Genetic, Oncogenic mutations, Mutation, Gene Expression Regulation, Leukemic, MESH: MutL Protein Homolog 1, MLH1, Myeloid leukemia, MESH: Drug Resistance, Neoplasm, 3. Good health, 030220 oncology & carcinogenesis, Gene Knockdown Techniques, MESH: Gene Expression Regulation, Leukemic, Molecular Medicine, Intercellular Signaling Peptides and Proteins, MutL Protein Homolog 1, Tyrosine kinase, medicine.drug_class, Down-Regulation, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, Cell Line, 03 medical and health sciences, Cellular and Molecular Neuroscience, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, MESH: Promoter Regions, Genetic, medicine, Animals, Humans, Point Mutation, MESH: Intercellular Signaling Peptides and Proteins, Molecular Biology, Protein Kinase Inhibitors, MESH: Mice, Janus Kinases, MESH: Point Mutation, Pharmacology, MESH: Humans, Point mutation, Janus kinase (JAK), MESH: Clone Cells, Cell Biology, Oncogenes, DNA Methylation, MESH: Gene Knockdown Techniques, Clone Cells, MESH: Cell Line, 030104 developmental biology, MESH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Drug resistance, Cancer research, Ectopic expression

  4. 4

    المساهمون: Institut Bergonié [Bordeaux], UNICANCER, Université Victor Segalen - Bordeaux 2, Université de Bordeaux (UB), Laboratoire d'hématologie, Centre National de la Recherche Scientifique (CNRS)

    المصدر: Disease Markers, Vol 30, Iss 5, Pp 221-227 (2011)
    Disease markers
    Disease Markers
    Disease Markers, Hindawi, 2021, 30 (5), pp.221-7. ⟨10.3233/DMA-2011-0777⟩

    وصف الملف: text/xhtml

  5. 5

    المساهمون: Physiologie Moléculaire de la Réponse Immune et des Lymphoproliférations (PMRIL), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Centre National de la Recherche Scientifique (CNRS), Service d'Hématologie [CHU Dupuytren], Hôpital Dupuytren [CHU Limoges], Laboratoire d'hématologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Bergonié [Bordeaux], UNICANCER, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Cancérologie (Inserm U599/IPC), Université de la Méditerranée - Aix-Marseille 2-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'Oncologie Génétique [Rouen] (CLCC Henri Becquerel), Service d'Hématologie clinique et thérapie cellulaire [CHU Limoges], CHU Limoges, Service d'Immunologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Carrion, Claire, Division Physico-chimie des Matériaux (LCPC/PCM), Laboratoire Central des Ponts et Chaussées (LCPC)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Haematologica
    Haematologica, Ferrata Storti Foundation, 2008, 93 (2), pp.215-23. ⟨10.3324/haematol.11622⟩
    Haematologica, 2008, 93 (2), pp.215-23. ⟨10.3324/haematol.11622⟩

  6. 6

    المساهمون: AGeing and IMagery (AGIM), Centre National de la Recherche Scientifique (CNRS)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Joseph Fourier - Grenoble 1 (UJF)-Université Pierre Mendès France - Grenoble 2 (UPMF), Laboratoire de Neurosciences Précliniques, Université Joseph Fourier - Grenoble 1 (UJF), Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Issartel, Jean-Paul

    المصدر: Experimental Hematology
    Experimental Hematology, Elsevier, 2008, 36 (1), pp.28-36. ⟨10.1016/j.exphem.2007.08.027⟩
    Experimental Hematology, 2008, 36 (1), pp.28-36. ⟨10.1016/j.exphem.2007.08.027⟩

    مصطلحات موضوعية: MESH: Neoplasm Proteins, MAPK/ERK pathway, Cancer Research, Pyridines, Apoptosis, Cell Cycle Proteins, MESH: Cell Cycle, Mitogen-activated protein kinase kinase, MESH: Monocytes, Monocytes, MESH: Drug Synergism, MAP2K7, 0302 clinical medicine, MESH: Protein Kinase Inhibitors, ASK1, Phosphoinositide-3 Kinase Inhibitors, Anthracenes, 0303 health sciences, Leukemia, Gene Expression Regulation, Leukemic, Kinase, MESH: Anthracenes, Cell Cycle, MESH: Drug Screening Assays, Antitumor, Imidazoles, Cell Differentiation, Drug Synergism, U937 Cells, Hematology, Neoplasm Proteins, 3. Good health, Cell biology, 030220 oncology & carcinogenesis, MESH: Gene Expression Regulation, Leukemic, MESH: Cell Division, Mitogen-Activated Protein Kinases, Cell Division, MESH: Imidazoles, MESH: Cell Differentiation, MESH: Cell Line, Tumor, MAP Kinase Signaling System, Morpholines, MESH: Morpholines, HL-60 Cells, MESH: U937 Cells, Biology, 03 medical and health sciences, MESH: Cell Cycle Proteins, MESH: HL-60 Cells, Cell Line, Tumor, MESH: Leukemia, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Genetics, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, c-Raf, Protein Kinase Inhibitors, Molecular Biology, 030304 developmental biology, MAPK14, Flavonoids, G protein-coupled receptor kinase, MESH: Humans, MESH: MAP Kinase Signaling System, MESH: Apoptosis, MESH: Pyridines, MESH: 1-Phosphatidylinositol 3-Kinase, Cell Biology, MESH: Mitogen-Activated Protein Kinases, Molecular biology, MESH: Chromones, Chromones, Drug Screening Assays, Antitumor, MESH: Flavonoids

  7. 7

    المساهمون: Microenvironnement cellulaire et moléculaire des tumeurs, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Service d'hématologie clinique, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Signalisation et Réponses aux Agents Infectieux et Chimiques (SeRAIC), Université de Rennes (UR), Université de Rennes (UR)-Hôpital Pontchaillou, Immunopathologie et chimie thérapeutique (ICT), Institut de biologie moléculaire et cellulaire (IBMC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Neoplasia
    Neoplasia, Elsevier, 2006, 8 (3), pp.223-30. ⟨10.1593/neo.05703⟩
    Neoplasia, 2006, 8 (3), pp.223-30. ⟨10.1593/neo.05703⟩
    Neoplasia, Elsevier, 2006, 8 (3), pp.223-230
    Neoplasia: An International Journal for Oncology Research, Vol 8, Iss 3, Pp 223-230 (2006)

    مصطلحات موضوعية: Cancer Research, MESH: Leukemia, Myeloid, MESH: Antigens, Neoplasm, immunomodulation, MESH: Histocompatibility Antigens Class I, 0302 clinical medicine, HLA Antigens, Leukemia-Lymphoma, Adult T-Cell, MESH: Leukemia-Lymphoma, Adult T-Cell, MESH: HLA Antigens, ComputingMilieux_MISCELLANEOUS, 0303 health sciences, Acute leukemia, MESH: Cytokines, Leukemia, biology, Gene Expression Regulation, Leukemic, Soluble human leukocyte antigen G (sHLA-G), MESH: Enzyme-Linked Immunosorbent Assay, Precursor Cell Lymphoblastic Leukemia-Lymphoma, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Burkitt Lymphoma, 3. Good health, Leukemia, Myeloid, 030220 oncology & carcinogenesis, Acute Disease, MESH: Gene Expression Regulation, Leukemic, Cytokines, MESH: Acute Disease, MESH: Tumor Escape, [SDV.IMM]Life Sciences [q-bio]/Immunology, Research Article, MESH: Cell Line, Tumor, Lymphoproliferative disorders, Enzyme-Linked Immunosorbent Assay, acute myeloblastic leukemia (AML), Human leukocyte antigen, Major histocompatibility complex, lcsh:RC254-282, MESH: HLA-G Antigens, T Acute Lymphoblastic Leukemia, 03 medical and health sciences, Immune system, acute lymphoblastic leukemia (ALL), Antigen, Antigens, Neoplasm, Cell Line, Tumor, MESH: Leukemia, Biomarkers, Tumor, medicine, Humans, Retrospective Studies, 030304 developmental biology, HLA-G Antigens, MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Humans, Histocompatibility Antigens Class I, MESH: Retrospective Studies, medicine.disease, MESH: Solubility, MESH: Burkitt Lymphoma, Solubility, Immunology, MESH: Tumor Markers, Biological, biology.protein, Tumor Escape, myelodysplasia

  8. 8

    المساهمون: Department of Biology and Biotechnology 'Charles Darwin', Institut Pasteur, Fondation Cenci Bolognetti - Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Department of Systems Biology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center (CUIMC), Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia (IIT), Réseau International des Instituts Pasteur (RIIP), This work was supported by FP7-PEOPLE-2011-ITN Project HemID (289611), Italian Epigenomics Flagship Project (EPIGEN) and ¿Research Projects of National Interest¿ (PRIN)., European Project: 289611,EC:FP7:PEOPLE,FP7-PEOPLE-2011-ITN,HEM_ID(2011), Hughes, James M., Salvatori, Beatrice, Giorgi, Federico M., Bozzoni, Irene, Fatica, Alessandro, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA)

    المصدر: Journal of Hematology and Oncology
    Journal of Hematology and Oncology, BioMed Central, 2014, 7, pp.69. ⟨10.1186/s13045-014-0069-1⟩
    Journal of Hematology & Oncology
    Journal of Hematology and Oncology, 2014, 7, pp.69. ⟨10.1186/s13045-014-0069-1⟩

    وصف الملف: ELETTRONICO

  9. 9

    المساهمون: Groupe innovation et ciblage cellulaire (GICC), EA 7501 [2018-...] (GICC EA 7501), Université de Tours (UT), CHU Amiens-Picardie, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Tours

    المصدر: Blood
    Blood, American Society of Hematology, 1996, 87 (5), pp.1692-1697. ⟨10.1182/blood.V87.5.1692.1692⟩

    مصطلحات موضوعية: MESH: Signal Transduction, MESH: Neoplasm Proteins, Transcription, Genetic, MESH: Base Sequence, Biochemistry, 0302 clinical medicine, hemic and lymphatic diseases, STAT5 Transcription Factor, STAT1, Promoter Regions, Genetic, STAT3, STAT4, STAT5, STAT6, MESH: Aged, 0303 health sciences, Leukemia, biology, Gene Expression Regulation, Leukemic, MESH: STAT3 Transcription Factor, Myeloid leukemia, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, DNA, Neoplasm, Hematology, Milk Proteins, Neoplasm Proteins, 3. Good health, DNA-Binding Proteins, STAT1 Transcription Factor, 030220 oncology & carcinogenesis, Acute Disease, MESH: Gene Expression Regulation, Leukemic, Neoplastic Stem Cells, MESH: Acute Disease, Signal Transduction, Adult, STAT3 Transcription Factor, MESH: Milk Proteins, MESH: Trans-Activators, Macromolecular Substances, Molecular Sequence Data, Immunology, MESH: DNA, Neoplasm, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], MESH: Leukemia, MESH: Promoter Regions, Genetic, Humans, Protein inhibitor of activated STAT, Aged, 030304 developmental biology, MESH: Humans, MESH: Molecular Sequence Data, Blood Cells, Base Sequence, MESH: Transcription, Genetic, MESH: Blood Cells, MESH: STAT5 Transcription Factor, MESH: Adult, MESH: Macromolecular Substances, Cell Biology, MESH: Neoplastic Stem Cells, Trans-Activators, Cancer research, biology.protein, STAT protein, MESH: STAT1 Transcription Factor, MESH: DNA-Binding Proteins

  10. 10

    المساهمون: Institut de Biologie Valrose (IBV), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Laboratoire d'hématologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Laboratoire d'Hématologie [Purpan], Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Transfert de Genes a Visee Therapeutique Dans les Cellules Souches, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Nice Sophia Antipolis (1965 - 2019) (UNS)

    المصدر: Blood
    Blood, American Society of Hematology, 2012, 120 (9), pp.1959-60. ⟨10.1182/blood-2012-02-408229⟩